Enzyme-triggered- and tumor-targeted delivery with tunable, methacrylated poly(ethylene glycols) and hyaluronic acid hybrid nanogels

References

• Amarsy I, Papot S, Gassera G. (2022). Stimuli-responsive metal complexes for biomedical applications. Angew. Chem. Int e202205900.
   PubMed Web of Science ®Google Scholar
• Amir MA, Khatoon F. (2019). Different types of smart nanogel for targeted delivery. J Sci Adv Mat Devices 4:201–12.
   Google Scholar
• Banerji S, Wright AJ, Noble M, et al. (2007). Structures of the Cd44–hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat Struct Mol Biol 14:234–9.
   PubMed Web of Science ®Google Scholar
• Bayer IS. (2020). Hyaluronic acid, and controlled release: a review. Molecules 25:2649–38.
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, et al. (2014). Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66:2–25.
   PubMed Web of Science ®Google Scholar
• Cadete A, Olivera A, Besev M, et al. (2019). Self-assembled hyaluronan nanocapsules for the intracellular delivery of anticancer drugs. Sci. Reports 9:11565–78.
   PubMed Web of Science ®Google Scholar
• Cai J, Fu J, Li R, et al. (2019). A potential carrier for anti-tumor targeted delivery hyaluronic acid nanoparticles. Carbohydr Polym 208:356–64.
   PubMed Web of Science ®Google Scholar
• Chen LL, Zheng YY, Feng LB, et al. (2019). Novel hyaluronic acid-coated hydrophobically modified chitosan polyelectrolyte complex for the delivery of Doxorubicin. Int J Biol Macromol 126:254–61.
   PubMed Web of Science ®Google Scholar
• Cheng L, Yang L, Meng F, Zhong Z. (2018). Protein nanotherapeutics as an emerging modality for cancer therapy. Adv Health Mater 7:1–9.
   Web of Science ®Google Scholar
• Choi KY, Min KH, Na JH, et al. (2009). Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution. J Mater Chem 19:4102–7.
   Web of Science ®Google Scholar
• Don TM, Lu KY, Lin LJ, et al. (2017). Temperature/pH/enzyme triple-responsive cationic protein/PAA-b-PNIPAAm nanogels for controlled anticancer drug and photosensitizer delivery against multidrug-resistant breast cancer cells. Mol Pharm 14:4648–60.
   PubMed Web of Science ®Google Scholar
• Dovedytis M, Liu ZJ, Bartlett S. (2020). Hyaluronic acid and its biomedical applications: a review. Eng Regen 1:102–13.
   Google Scholar
• Duncan R. (2003). The dawning era of polymer therapeutics. Nat Rev Drug Discov 2:347–60.
   PubMed Web of Science ®Google Scholar
• Furtado D, Bjornmalm M, Ayton S, et al. (2018). Overcoming the blood-brain barrier. The role of nanomaterials in treating neurological diseases. Adv Mater 30:1801362–6.
   PubMed Web of Science ®Google Scholar
• Gao Q, Zhang CM, Zhang EX, et al. (2019). Zwitterionic pH-responsive hyaluronic acid polymer micelles for delivery of Doxorubicin. Colloids Surf B Biointerfaces 178:412–20.
   PubMed Web of Science ®Google Scholar
• Grimaudo MA, Concheiro A, Alvarez-Lorenzo C. (2019). Nanogels for regenerative medicine. J Control Release 313:148–60.
   PubMed Web of Science ®Google Scholar
• Huai Y, Hossen MN, Wilhelm S, et al. (2019). Nanoparticle interactions with the tumor microenvironment. Bioconjug Chem 30:2247–63.
   PubMed Web of Science ®Google Scholar
• ISO 10993-5:2009. (2009). Biological evaluation of medical devices. Part 5: tests for in vitro cytotoxicity. http://www.iso.org/iso/catalogue_detail.htm?csnumber=36406.
   Google Scholar
• Karbarz M, Mackiewicz M, Kaniewska K, et al. (2017). Recent developments in design and functionalization of micro- and nanostructural environmentally-sensitive hydrogels based on -isopropylacrylamide. Appl Mat Today 9:516–32.
   Web of Science ®Google Scholar
• Kim K, Choi H, Choi ES, et al. (2019). Hyaluronic acid-coated nanomedicine for targeted cancer therapy. Pharmaceutics 11:301–22.
   PubMed Web of Science ®Google Scholar
• Kim JH, Moon MJ, Kim DY, et al. (2018). Hyaluronic acid-based nanomaterials for cancer therapy. Polymers 10:1133–15.
   PubMed Web of Science ®Google Scholar
• Klapdor R, Wang S, Morgan M, et al. (2021). NK cell-mediated eradication of ovarian cancer cells with a novel chimeric antigen receptor directed against CD44. Biomedicines 9:1339–45.
   PubMed Web of Science ®Google Scholar
• Leach JB, Schmidt CE. (2005). Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds. Biomaterials 26:125–35.
   PubMed Web of Science ®Google Scholar
• Lee DE, Kim AY, Yoon H, et al. (2012). Amphiphilic hyaluronic acid-based nanoparticles for tumor-specific optical/MR dual imaging. J Mater Chem 22:10444–7.
   Web of Science ®Google Scholar
• Li M, Sun J, Zhang J, et al. (2021). Drug delivery systems based on CD44-targeted glycosaminoglycans for cancer therapy. Carbohyd. Polym 251:1–20.
   Web of Science ®Google Scholar
• Liu M, Tolg C, Turley E. (2019). Dissecting the dual nature of hyaluronan in the tumor microenvironment. Front Immunol 10:1–9.
   PubMed Web of Science ®Google Scholar
• Liu R, Xiao W, HuXie CR, et al. (2018). Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with the optimal size for combinational treatment of breast cancer and lung metastasis. J Control Release 278:127–39.
   PubMed Web of Science ®Google Scholar
• Li Z, Van Zee NJ, Bates FS, Lodge TP. (2019). Polymer nanogels as reservoirs to inhibit hydrophobic drug crystallization. ACS Nano 13:1232–43.
   PubMed Web of Science ®Google Scholar
• Liwinska W, Stanislawska I, Lyp M, et al. (2017). A degradable nanogel drug carrier crosslinked with three-oligonucleotide hybrids for two-way drug release in mild and high hyperthermia treatment. J Mater Chem B 5:4713–24.,
   PubMed Web of Science ®Google Scholar
• Liwinska W, Stanislawska I, Lyp M, et al. (2019). Switchable conformational changes of DNA nanogel shells containing disulfide-DNA hybrids for controlled drug release and efficient anticancer action. RSC Adv 9:13736–48.
   PubMed Web of Science ®Google Scholar
• Liwinska W, Symonowicz M, Stanislawska I, et al. (2016). Environmentally sensitive nanohydrogels decorated with a three-strand oligonucleotide helix for controlled loading and prolonged release of intercalators. RSC Adv 6:91045–59.,
   Web of Science ®Google Scholar
• Li W, Yi X, Liu X, et al. (2016). Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. J Control Release 225:170–82.
   PubMed Web of Science ®Google Scholar
• Mackiewicz M, Dagdelen S, Marcisz K, et al. (2021). Redox-degradable microgel based on poly(acrylic acid) as drug-carrier with very high drug-loading capacity and decreased toxicity against healthy cells. Polym Degrad Stability 190:1–10.
   Web of Science ®Google Scholar
• Mackiewicz M, Romanski J, Drabczyk K, et al. (2019). Degradable, thermo-, ph-and redox-sensitive hydrogel microcapsules for burst and sustained release of drugs. Int J Pharmaceut 569:1–10.
   Web of Science ®Google Scholar
• Mackiewicz M, Romanski J, Krug P, et al. (2019). Tunable environmental sensitivity and degradability of nanogels based on derivatives of cysteine and poly(ethylene glycols) of various lengths for biocompatible drug carrier. Europ Polymer J 118:606–13.
   Web of Science ®Google Scholar
• Ma JF, Deng HZ, Zhao FL, et al. (2018). Liposomes-camouflaged reDOX responsive nanogels to resolve the dilemma between extracellular stability and intracellular drug release. Macromol Biosci 18:1800049–10.
   Web of Science ®Google Scholar
• Ma Z, Foda MF, Zhao Y, Han H. (2022). Multifunctional nanosystems with enhanced cellular uptake for tumor therapy. Adv Healthcare Mat 11:1–21.
   Web of Science ®Google Scholar
• Makra I, Terejanszky P, Gyurcsanyi RE. (2015). A method based on light scattering to estimate the concentration of virus particles without the need for virus particle standards. Methods X 2:91–9.
   PubMedGoogle Scholar
• Massi L, Najer A, Chapman R, et al. (2020). Tunable peptide cross-linked nanogels for enzyme-triggered protein delivery. J Mater Chem B 8:8894–907.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang B, Shao H, et al. (2022). Hydrogels for localized chemotherapy of liver cancer: a possible strategy for improved and safe liver cancer treatment. Drug Deliv 29:2130–61.
   PubMed Web of Science ®Google Scholar
• Mei H, Cai S, Huang D, et al. (2022). Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: from intrinsic physicochemical properties to external modification. Bioact Mater 8:220–40.
   PubMed Web of Science ®Google Scholar
• Mi P, Cabral H, Kataoka K. (2020). Ligand-installed nanocarriers toward precision therapy. Adv Mater 32:1902604–29.
   PubMed Web of Science ®Google Scholar
• Miao T, Wang J, Zeng Y, et al. (2018). Polysaccharide-based controlled release systems for therapeutics delivery and tissue engineering: from bench to bedside. Adv Sci (Weinh) 5:1700513–32.,
   PubMedGoogle Scholar
• Min Y, Caster JM, Eblan MJ, Wang AZ. (2015). Clinical translation of nanomedicine. Chem Rev 115:11147–90.
   PubMed Web of Science ®Google Scholar
• Misra S, Hascall VC, Markwald RR, Ghatak S. (2015). Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front Immunol 6:201–30.
   PubMed Web of Science ®Google Scholar
• Mollazadeh S, Mackiewicz M, Yazdimamaghani M. (2021). Recent advances in the redox-responsive drug delivery nanoplatforms: a chemical structure and physical property perspective. Mat Sci Eng C 118:1–20.
   Web of Science ®Google Scholar
• Payne WM, Vechkarev D, Kyrychenko A, Mohs AM. (2018). The role of hydrophobic modification on hyaluronic acid dynamics and self-assembly. Carbohydr Polym 182:131–41.
   Web of Science ®Google Scholar
• Preman NK, Jain S, Johnson RP. (2021). “Smart” polymer nanogels as pharmaceutical carriers: a versatile platform for programmed delivery and diagnostics. ACS Omega 6:5075–90.
   PubMed Web of Science ®Google Scholar
• Shin JM, Oh SJ, Kwon S, et al. (2017). A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy. J Control Release 267:181–90.
   PubMed Web of Science ®Google Scholar
• Snetkov P, Zakharova K, Morozkina S, et al. (2020). Hyaluronic acid: the influence of molecular weight on structural, physical, physico-chemical, and degradable properties of biopolymer. Polymers 12:18001800.
   Web of Science ®Google Scholar
• Spadea A, Rios de la Rosa JM, Tirella A, et al. (2019). Evaluating the efficiency of hyaluronic acid for tumor targeting via CD44. Mol Pharm 16:2481–93.
   PubMed Web of Science ®Google Scholar
• Stanislawska I, Liwinska W, Lyp M, et al. (2019). Recent advances in degradable hybrids of biomolecules and NGS for targeted delivery. Molecules 24:1–32.
   Web of Science ®Google Scholar
• Stawicki B, Schacher T, Cho H. (2021). Nanogels as a versatile drug delivery system for brain cancer. Gels 7:63.
   PubMed Web of Science ®Google Scholar
• Tian Y, Bromberg L, Lin SN, et al. (2007). Complexation and release of Doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymers. J Control Release 121:137–45.,
   PubMed Web of Science ®Google Scholar
• Toraya-Brown S, Fiering S. (2014). Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia 30:531–9.
   PubMed Web of Science ®Google Scholar
• Valachová K, Baňasová M, Topoľská D, et al. (2015). Influence of tiopronin, captopril and levamisole therapeutics on the oxidative degradation of hyaluronan. Carbohydr Polym 134:516–23.
   PubMed Web of Science ®Google Scholar
• Valachová K, Topoľská D, Mendichi R, et al. (2016). Hydrogen peroxide generation by the Weissberger biogenic oxidative system during hyaluronan degradation. Carbohydr Polym 148:189–93.,
   PubMed Web of Science ®Google Scholar
• Waleka E, Mackiewicz M, Romanski Dybko JA, et al. (2020). Degradable nanohydrogel with high doxorubicin loadings exhibiting controlled drug release and decreased toxicity against healthy cells. Int J Pharmaceut 579:1–9.
   Web of Science ®Google Scholar
• Wenxing G, Fenghua M, Rainer H, Zhiyuan Z. (2021). Actively targeted nanomedicines for precision cancer therapy: concept, construction, challenges and clinical translation. J Control Release 329:676–95.
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhang Q, Yu T, et al. (2021). Self-assembled hybrid nanogel as a multifunctional theranostic probe for enzyme-regulated ultrasound imaging and tumor therapy. ACS Appl Bio Mater 4:4244–53.
   PubMedGoogle Scholar
• Xu CF, Iqbal S, Shen S, et al. (2019). Development of "CLAN" nanomedicine for nucleic acid therapeutics. Small 15:1900055–19.
   Web of Science ®Google Scholar
• Yan J, Zhang N, Zhang Z, et al. (2022). Redox-responsive polyethyleneimine/tetrahedron DNA/doxorubicin nanocomplexes for deep cell/tissue penetration to overcome multidrug resistance. Drug Deliv 29:1457–76.
   PubMed Web of Science ®Google Scholar
• Yin Y, Hu B, Yuan X, et al. (2020). Nanogel: a versatile nano-delivery system for biomedical applications. Pharmaceutics 12:29025.
   Web of Science ®Google Scholar
• Zhao TC, Wang PY, Li Q, et al. (2018). Near-infrared triggered decomposition of nanocapsules with high tumor accumulation and stimuli-responsive fast elimination. Angew Chem Int Ed Engl 57:2611–5.
   PubMed Web of Science ®Google Scholar